Frederick J. Dechow
Keine laufenden Positionen mehr
Profil
Frederick J.
Dechow served as President & CEO at BioCryst Pharmaceuticals, President & CEO at PrimeCyte, President, CEO & Director at MediQuest Therapeutics, President & CEO at Gem Pharmaceuticals LLC, Vice President-Research & Development at Reed & Carnrick Pharmaceuticals, and held a Principal position at The Dow Chemical Co. and Ciba-Geigy Pharmaceuticals.
Dechow holds a doctorate degree from Iowa State University and an undergraduate degree from the University of Hawai'i at Hilo.
Ehemalige bekannte Positionen von Frederick J. Dechow
| Unternehmen | Position | Ende |
|---|---|---|
| PrimeCyte, Inc. | Vorstandsvorsitzender | 01.01.2002 |
Gem Pharmaceuticals LLC
 Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL. | Vorstandsvorsitzender | 01.01.2001 |
| PREMD INC. | Geschäftsführer | 01.01.1996 |
| BIOCRYST PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 01.01.1994 |
| Reed & Carnrick Pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1989 |
Ausbildung von Frederick J. Dechow
| Iowa State University | Doctorate Degree |
| University of Hawai'i at Hilo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
| PrimeCyte, Inc. | Commercial Services |
PreMD, Inc.
 PreMD, Inc. Medical SpecialtiesHealth Technology PreMD, Inc. engages in manufacturing and distribution of pharmaceutical products. The company was founded by H. B. Brent Norton on November 9, 1992 and is headquartered in Toronto, Canada. | Health Technology |
MediQuest Therapeutics, Inc.
 MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA. | Health Technology |
| Reed & Carnrick Pharmaceuticals | |
| Ciba-Geigy Pharmaceuticals | |
Gem Pharmaceuticals LLC
Gem Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Gem Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company that develops anthracycline derivatives used to eliminate cardiotoxicity side effect in chemotherapeutics. The company is headquartered in Birmingham, AL. | Health Technology |
